Medipost said Wednesday that it has acquired a patent in Japan on stem cell culture fluids that prevent hair loss.
The patent titled “Hair growth-promoting function of small-sized stem cells and use thereof” relates to the development of a composition for preventing hair loss and promoting hair growth.
“The patented technology proves that small mesenchymal stem cells isolated from umbilical cord blood or its culture have excellent hair loss prevention and hair growth promoting effect,” a company official said.
The company has been researching stem cell cultures related to hair loss since 2013 as part of the industrial core technology development project supported by the Ministry of Trade, Industry and Energy (MOTIE) and the Korea Evaluation Institute of Industrial Technology.
Medipost plans to use the patented technology to develop hair loss-related products. With the addition of the patent the company now owns 76 patents related to the cord blood technology.